Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Multimodality imagers play a critical role in modern heart teams
Heart teams continue to play a major role at hospitals and health systems all over the world. Cardiac imagers who have trained in multiple modalities can provide those teams with a significant amount of value.
Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries
Safety concerns with certain Boston Scientific leads has resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August.
FDA clears AI-powered cardiac imaging platform
The Tempus Pixel platform was designed to assist clinicians with the evaluation of cardiac MR images.
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Open-source AI model delivers accurate echocardiography assessments
The algorithm, trained on more than 150,000 TTE studies, can calculate 18 different measurements regularly used in echocardiography

Medical association releases consensus statement on intra-coronary imaging

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) has published a clinical guidance statement regarding the use of intra-coronary imaging (IC), sharing the document during its EuroPCR Annual Meeting, May 21-24 in Paris.

Abbott’s tricuspid valve repair system finds success in TRILUMINATE study

Results from the TRILUMINATE study, presented this week at EuroPCR 2019 in Paris, suggest Abbott’s minimally invasive tricuspid valve repair system is an effective solution for patients with structural heart disease, reducing the severity of tricuspid regurgitation (TR) in more than 85% of test cases.

Radiologists performing fewer myocardial perfusion imaging exams

A recent decline in myocardial perfusion imaging (MPI) utilization has been attributed to legislative efforts, decreasing reimbursement and consolidation, but is that truly the case?

First personal 6-lead ECG cleared for sale in US

AliveCor has been granted FDA clearance for KardiaMobile 6L, the world’s first publicly available six-lead personal electrocardiogram device.

SHINE gains exclusive license for Lu-177 radioisotope production

Janesville, Wisconsin-based SHINE Medical Technologies has announced an agreement with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), gaining exclusive rights over an innovation to produce lutetium-177 (Lu-177).

Wait times for heart scans reach 5-year highs in Winnipeg

At one institution wait times for myocardial perfusion tests have jumped from six to 18 weeks in less than a year, according to data from Manitoba Health.

Making the Case for Cardiac PET: Before Buying in, Evaluate Clinical & Business Considerations

While the clinical case for cardiac PET is compelling, it also has to be feasible from a financial and logistical standpoint.

Arsenic in drinking water linked to LV thickening, hypertrophy

Drinking water contaminated with inorganic arsenic could increase young adults’ risk of CVD by thickening the heart’s left ventricular (LV) wall and triggering hypertrophy, researchers reported in Circulation: Cardiovascular Imaging May 7.

Cardiac Imaging

Multimodality imagers play a critical role in modern heart teams

Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries

FDA clears AI-powered cardiac imaging platform

Key trends in nuclear cardiology take center stage at ASNC 2025

Open-source AI model delivers accurate echocardiography assessments